MKI67 and cervical small cell carcinoma: In conclusion, our study provided the initial evidence that Ki-67 could serve as a prognostic factor for SCCE, and more importantly, Ki-67 expression level could also serve as an indication of providing adjuvant therapy for SCCE patients with surgical resection in clinical practice.